Multaun en es it fr

Multaun Brand names, Multaun Analogs

Multaun Brand Names Mixture

  • No information avaliable

Multaun Chemical_Formula


Multaun RX_link

No information avaliable

Multaun fda sheet

Multaun msds (material safety sheet)

Multaun Synthesis Reference

No information avaliable

Multaun Molecular Weight

309.469 g/mol

Multaun Melting Point

< 25 oC

Multaun H2O Solubility

Soluble as HCl salt

Multaun State


Multaun LogP


Multaun Dosage Forms

Tablets (oral, 1 mg)

Multaun Indication

Used for the symptomatic treatment of parkinsonism.

Multaun Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Multaun Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Multaun side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Multaun Patient Information

Multaun Organisms Affected

Humans and other mammals